MARKET

NDRAW

NDRAW

ENDRA LIFE SCNCS
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.4595
-0.0154
-3.24%
Closed 16:00 09/17 EDT
OPEN
0.4150
PREV CLOSE
0.4749
HIGH
0.4747
LOW
0.3078
VOLUME
16.35K
TURNOVER
--
52 WEEK HIGH
0.9700
52 WEEK LOW
0.0601
MARKET CAP
30.24M
P/E (TTM)
-0.6435
1D
5D
1M
3M
1Y
5Y
ENDRA Life Sciences to Participate in Two Upcoming Investment Conferences
ANN ARBOR, MI / ACCESSWIRE / September 7, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in two upcoming virtual investment conferences.
ACCESSWIRE · 09/07 12:00
BRIEF-Endra Life Sciences Q2 Loss Per Share $0.08
reuters.com · 08/12 22:10
ENDRA Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update
Conference call begins at 4:30 p. Eastern time todayANN ARBOR, MI / ACCESSWIRE / August 12, 2021 /ENDRA Life Sciences Inc.
ACCESSWIRE · 08/12 20:05
ENDRA Life Sciences to Report Second Quarter 2021 Financial Results on August 12, 2021
ANN ARBOR, MI / ACCESSWIRE / August 2, 2021 /ENDRA Life Sciences Inc. (ENDRA) (NASDAQ:NDRA), a pioneer of enhanced ultrasound technologies, today announced that the company will report financial results for the second quarter of 2021 on Thursday, August 12...
ACCESSWIRE · 08/02 12:00
ENDRA Life Sciences Announces Participation in A.G.P.'s Virtual MedTech Summer Conference on July 29, 2021
ANN ARBOR, MI / ACCESSWIRE / July 20, 2021 / ENDRA Life Sciences Inc. (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that management will participate in A.
ACCESSWIRE · 07/20 12:00
ENDRA Life Sciences Strengthens TAEUS(R) System Intellectual Property Protection with the Issuance of Three U.S. Patents
ANN ARBOR, MI / ACCESSWIRE / July 7, 2021 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces the strengthening of its global patent portfolio with the issuance of the 17th, 18th and 19th...
ACCESSWIRE · 07/07 12:00
BRIEF-Endra Life Sciences Inc Enters Into An At-The-Market Issuance Sales Agreement With Ascendiant Capital Markets
reuters.com · 06/21 21:07
BRIEF-Endra Life Sciences Inc - On June 9, David Wells Notified Co Of His Resignation As CFO, Effective June 18, 2021
reuters.com · 06/15 13:45
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NDRAW. Analyze the recent business situations of ENDRA LIFE SCNCS through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
+0.49%
Pharmaceuticals & Medical Research
-0.10%
Key Executives
Chairman/Chief Executive Officer/Director
Francois Michelon
Chief Financial Officer/Senior Director
Irina Pestrikova
Chief Technology Officer
Michael Thornton
Other
Renaud Maloberti
Independent Director
Louis Basenese
Independent Director
Anthony DiGiandomenico
Independent Director
Sanjiv Gambhir
Independent Director
Michael Harsh
Independent Director
Alexander Tokman
No Data
About NDRAW
ENDRA Life Sciences Inc. is engaged in commercialization of an ultrasound technology for the pre-clinical research market. The Company’s Nexus 128 system, which combines light-based thermoacoustics and ultrasound to address the imaging needs of researchers studying disease models in pre-clinical applications. The Company has developed a technology platform, Thermo Acoustic Enhanced Ultrasound (TAEUS), which is intended to enhance the capability of clinical ultrasound technology and support the diagnosis. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.

Webull offers kinds of ENDRA Life Sciences Inc stock information, including NASDAQ:NDRAW real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NDRAW stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NDRAW stock methods without spending real money on the virtual paper trading platform.